Calreticulin mediated glucocorticoid receptor export is involved in β-catenin translocation and Wnt signalling inhibition in human osteoblastic cells

Bone

Volumn 44, Issue 4, 2009, Pages 555-565

  Olkku, Anu ^a   Mahonen, Anitta ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

catenin; Calreticulin; Glucocorticoids; Osteoblast; Wnt signalling

Indexed keywords

BETA CATENIN; CALRETICULIN; CHAPERONE; CYCLIN D1; DNA; GLUCOCORTICOID RECEPTOR; RNA; WNT PROTEIN;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL MEMBRANE; CELL NUCLEUS; CELL SURFACE; COMPETITIVE INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFORMATION; MOLECULAR INTERACTION; NUCLEAR EXPORT SIGNAL; NUCLEOTIDE BINDING SITE; OSTEOBLAST; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

BETA CATENIN; BLOTTING, WESTERN; CALRETICULIN; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOCORTICOIDS; HUMANS; IMMUNOPRECIPITATION; OSTEOBLASTS; PROTEIN TRANSPORT; RECEPTOR CROSS-TALK; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION; WNT PROTEINS;

EID: 61749091734     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.11.013     Document Type: Article

References (62)

1. Cadigan K.M., and Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 11 (1997) 3286-3305
2. Glass 2nd D.A., and Karsenty G. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. Curr. Top. Dev. Biol. 73 (2006) 43-84
3. Gregory C.A., Gunn W.G., Reyes E., Smolarz A.J., Munoz J., Spees J.L., et al. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Ann. N. Y. Acad. Sci. 1049 (2005) 97-106
4. Johnson M.L., Harnish K., Nusse R., and Van Hul W. LRP5 and Wnt signaling: a union made for bone. J. Bone Miner. Res. 19 (2004) 1749-1757
5. Koya M.A., and Brown M.A. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton. Trends Mol. Med. 11 (2005) 129-137
6. Westendorf J.J., Kahler R.A., and Schroeder T.M. Wnt signaling in osteoblasts and bone disease. Gene 341 (2004) 19-39
7. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 16 (2001) 513-523
8. Krishnan V., Bryant H.U., and MacDougald O.A. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116 (2006) 1202-1209
9. Glass II D.A., Bialek P., Ahn J.D., Starbuck M., Patel M.S., Clevers H., et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8 (2005) 751-764
10. Bodine P.V.N., and Komm B.S. Wnt signaling and osteoblastogenesis. Rev. Endocr. Metab. Disord. 7 (2006) 33-39
11. Hartmann C.A. Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol. 16 (2006) 151-158
12. Bodine P.V., Billiard J., Moran R.A., Ponce-de-Leon H., McLarney S., Mangine A., et al. The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J. Cell. Biochem. 96 (2005) 1212-1230
13. Willert K., and Nusse R. β-catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev. 8 (1998) 95-102
14. Kikuchi A. Regulation of β-catenin signaling in the Wnt pathway. Biochem. Biophys. Res. Commun. 268 (2000) 243-248
15. Canalis E., Mazziotti G., Giustina A., and Bilezikian J.P. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos. Int. 18 (2007) 1319-1328
16. Canalis E. Mechanisms of glucocorticoid action in bone. Curr. Osteoporos. Rep. 3 (2005) 98-102
17. Pennisi P., Trombetti A., and Rizzoli R. Glucocorticoid-induced osteoporosis and its treatment. Clin. Orthop. Relat. Res. 443 (2006) 39-47
18. Mulholland D.J., Dedhar S., Coetzee G.A., and Nelson C.C. Interaction of nuclear receptors with the Wnt/β-catenin/Tcf signaling axis: Wnt you like to know?. Endocr. Rev. 26 (2005) 898-915
19. Shah S., Hecht A., Pestell R., and Byers S.T. Trans-repression of β-catenin activity by nuclear receptors. J. Biol. Chem. 28 (2003) 48137-48145
20. Shah S., Pishvaian M.J., Easwaran V., Brown P.H., and Byers S.W. The role of cadherin, beta-catenin, and AP-1 in retinoid-regulated carcinoma cell differentiation and proliferation. J. Biol. Chem. 277 (2002) 25313-25322
21. Easwaran V., Pishvaian M., Salimuddin, and Byers S. Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Curr. Biol. 9 (1999) 1415-1418
22. Shah S., Islam M.N., Dakshanamurthy S., Rizvi I., Rao M., Herrell R., et al. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol. Cell 21 (2006) 799-809
23. Li H., Kim J.H., Koh S.S., and Stallcup M.R. Synergistic effects of coactivators GRIP1 and beta-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways. J. Biol. Chem. 279 (2004) 4212-4220
24. Wang F.S., Lin C.H., Chen Y.J., Wang C.J., Yang K.D., Huang Y.T., et al. Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrine 146 (2005) 2415-2423
25. Smith E., and Frenkel B. Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3β-dependent and -independent manner. J. Biol. Chem. 280 (2005) 2388-2394
26. Ohnaka K., Tanabe M., Kawate H., Nawata H., and Takayanagi R. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem. Biophys. Res. Commun. 329 (2005) 177-181
27. Wakui H., Wright A.P., Gustafsson J.Å., and Zilliacus J. Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein. J. Biol. Chem. 272 (1997) 8153-8156
28. Harada K., Okiyoneda T., Hashimoto Y., Ueno K., Nakamura K., Yamahira K., et al. Calreticulin negatively regulates the cell surface expression of cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 281 (2006) 12841-12848
29. Olkku A., Bodine P.V.N., Linnala-Kankkunen A., and Mahonen A. Glucocorticoids induce glutamine synthetase expression in human osteoblastic cells: a novel observation in bone. Bone 34 (2004) 320-329
30. Spence J., Duggan B.M., Eckhardt C., McClelland M., and Mercola D. Messenger RNAs under differential translational control in Ki-ras-transformed cells. Mol. Cancer Res. 4 (2006) 47-60
31. Ryhanen S., Pirskanen A., Jaaskelainen T., and Maenpaa P.H. State of methylation of the human osteocalcin gene in bone-derived and other types of cells. J. Cell Biochem. 66 (1997) 404-412
32. Burns K., Duggan B., Atkinson E.A., Famulski K.S., Nemer M., Bleackley R.C., et al. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 367 (1994) 476-480
33. Dedhar S., Rennie P.S., Shago M., Hagesteijn C.Y., Yang H., Filmus J., et al. Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367 (1994) 480-483
34. Roura S., Miravet S., Piedra J., de Herreros A.G., and Duñach M. Regulation of E-cadherin/catenin association by tyrosine phosphorylation. J. Biol. Chem. 274 (1999) 36734-36740
35. Black B.E., Holaska J.M., Rastinejad F., and Paschal B.M. DNA binding domains in diverse nuclear receptors function as nuclear export signals. Curr. Biol. 11 (2001) 1749-1758
36. Baron R., Rawadi G., and Roman-Roman S. Wnt signaling: a key regulator of bone mass. Curr. Top. Dev. Biol. 76 (2006) 103-127
37. Piters E., Boudin E., and Van Hul W. Wnt signaling: a win for bone. Arch. Biochem. Biophys. 473 (2008) 112-116
38. Holmen S.L., Zylstra C.R., Mukherjee A., Sigler R.E., Faugere M.C., Bouxsein M.L., et al. Essential role of β-catenin in postnatal bone acquisition. J. Biol. Chem. 280 (2005) 21162-21168
39. Deregowski V., Gazzerro E., Priest L., Rydziel S., and Canalis E. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/β-catenin but not bone morphogenetic protein signaling. J. Biol. Chem. 281 (2006) 6203-6210
40. Ohnaka K., Taniguchi H., Kawate H., Nawata H., and Takayanagi R. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of GC-induced osteoporosis. Biochem. Biophys. Res. Commun. 318 (2004) 259-264
41. Olkku A., and Mahonen A. Wnt and steroid pathways control glutamate signalling by regulating glutamine synthetase activity in osteoblastic cells. Bone 43 (2008) 483-493
42. Orford K., Crockett C., Jensen J.P., Weissman A.M., and Byers S.W. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J. Biol. Chem. 272 (1997) 24735-24738
43. Hinoi T., Yamamoto H., Kishida M., Takada S., Kishida S., and Kikuchi A. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin. J. Biol. Chem. 275 (2000) 34399-34406
44. Mulholland D.J., Cheng H., Reid K., Rennie P.S., and Nelson C.C. The androgen receptor can promote β-catenin nuclear translocation independently of adenomatous polyposis coli. J. Biol. Chem. 277 (2002) 17933-17943
45. Pawlowski J.E., Ertel J.R., Allen M.P., Xu M., Butler C., Wilson E.M., et al. Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells. J. Biol. Chem. 277 (2002) 20702-20710
46. Guan Y., Rubenstein N.M., Failor K.L., Woo P.L., and Firestone G.L. Glucocorticoids control β-catenin protein expression and localization through distinct pathways that can be uncoupled by disruption of signaling events required for tight junction formation in rat mammary epithelial tumor cells. Mol. Endocrinol. 18 (2004) 214-227
47. Takayama S., Rogatsky I., Schwarcz L.E., and Darimont B.D. The glucocorticoid receptor represses cyclin D1 by targeting the TCF/β-catenin complex. J. Biol. Chem. 281 (2006) 17856-17863
48. Ossareh-Nazari B., Bachelerie F., and Dargemont C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278 (1997) 141-144
49. Kutay U., Bischoff F.R., Kostka S., Kraft R., and Görlich D. Export of importin α from nucleus is mediated by specific nuclear transport factor. Cell 90 (1997) 1061-1072
50. Holaska J.M., Black B.E., Love D.C., Hanover J.A., Leszyk J., and Paschal B.M. Calreticulin is a receptor for nuclear export. J. Cell Biol. 152 (2001) 127-140
51. Roderick H.L., Campbell A.K., and Llewellyn D.H. Nuclear localisation of calreticulin in vivo is enhanced by its interaction with glucocorticoid receptors. FEBS Lett. 405 (1997) 181-185
52. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., and Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352 (1991) 497-505
53. Fadel M.P., Szewczenko-Pawlikowski M., Leclerc P., Dziak E., Symonds J.M., Blaschuk O., et al. Calreticulin affects beta-catenin-associated pathways. J. Biol. Chem. 276 (2001) 27083-27089
54. Piedra J., Martinez D., Castaño J., Miravet S., Duñach M., and de Herreros A.G. Regulation of β-catenin structure and activity by tyrosine phosphorylation. J. Biol. Chem. 276 (2001) 20436-20443
55. Li G., and Iyengar R. Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/beta-catenin-regulated cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13254-13259
56. Benetti R., Copetti T., Dell'Orso S., Melloni E., Brancolini C., Monte M., et al. The calpain system is involved in the constitutive regulation of beta-catenin signaling functions. J. Biol. Chem. 280 (2005) 22070-22080
57. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5522-5527
58. Mesaeli N., Nakamura K., Zvaritch E., Dickie P., Dziak E., Krause K.H., et al. Calreticulin is essential for cardiac development. J. Cell Biol. 144 (1999) 857-868
59. Henderson B.R. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat. Cell Biol. 2 (2000) 653-660
60. Rosin-Arbesfeld R., Cliffe A., Brabletz T., and Bienz M. Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription. EMBO J. 22 (2003) 1101-1113
61. Hendriksen J., Fagotto F., van der Velde H., van Schie M., Noordermeer J., and Fornerod M. RanBP3 enhances nuclear export of active (beta)-catenin independently of CRM1. J. Cell Biol. 171 (2005) 785-797
62. Thorne M.E., and Gottardi C.J. Terminating Wnt signals: a novel nuclear export mechanism targets activated (beta)-catenin. J. Cell Biol. 171 (2005) 761-763